4.5 Article

Identification of a new transmembrane adaptor protein that constitutively binds Grb2 in B cells

Journal

JOURNAL OF LEUKOCYTE BIOLOGY
Volume 84, Issue 3, Pages 842-851

Publisher

FEDERATION AMER SOC EXP BIOL
DOI: 10.1189/jlb.0208087

Keywords

marginal zone B cells; BCR signaling; B cell proliferation

Funding

  1. National Institutes of Heath [AI048674, AI056156]

Ask authors/readers for more resources

Transmembrane adaptor proteins couple antigen receptor engagement to downstream signaling cascades in lymphocytes. One example of these proteins is the linker for activation of T cells (LAT), which plays an indispensable role in T cell activation and development. Here, we report identification of a new transmembrane adaptor molecule, namely growth factor receptor- bound protein 2 ( Grb2)- binding adaptor protein, transmembrane ( GAPT), which is expressed in B cells and myeloid cells. Similar to LAT, GAPT has an extracellular domain, a transmembrane domain, and a cytoplasmic tail with multiple Grb2- binding motifs. In contrast to other transmembrane adaptor proteins, GAPT is not phosphorylated upon BCR ligation but associates with Grb2 constitutively through its prolinerich region. Targeted disruption of the gapt gene in mice affects neither B cell development nor a nitrophenylacetyl- specific antibody response. However, in the absence of GAPT, B cell proliferation after BCR cross- linking is enhanced. In aged GAPT(-/-) mice, the number of marginal zone ( MZ) B cells is increased, and other B cell subsets are normal. The serum concentrations of IgM, IgG2b, and IgG3 are also elevated in these mice. These data indicate that GAPT might play an important role in control of B cell activation and proper maintenance of MZ B cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available